RELEASED 7 JUNE 2019
9th Conference of the International Lymphoedema Framework brings together lymphoedema experts from around the world in Chicago, USA
The International Lymphoedema Framework (ILF) is proud to present its 9th International Lymphoedema Framework Conference, to take place in Chicago, Illinois, USA, 13–15 June 2019. The conference is co-hosted with the American Lymphedema Framework Project (ALFP). This is the first time the conference will be held in the United States.
Lymphoedema is an under-recognised and global health problem, with many patients going undiagnosed and untreated. The ILF strives to raise awareness of the prevention and treatment of lymphoedema throughout the world. Their annual conference not only provides an educational opportunity but also highlights the work of both the ILF and ALFP. The conference is multidisciplinary and patient-focused, with an emphasis on improving lymphoedema outcomes though innovation and collaboration. Approximately 400 participants from around the world—representing healthcare professionals, patients, researchers, and industry—are expected in Chicago.
The conference’s 3-day, comprehensive scientific program includes more than 175 presentations given in plenary sessions, abstract sessions, and poster presentations. The conference also features several industry symposia as well as a fully booked exhibition hall, with 35 companies and organisations showcasing their products and services.
The conference program presents a wide range of lymphoedema-related topics, such as risk reduction, lymphatic in health and disease, advances in diagnostics, chronic wounds, and compression challenges. The international roster of speakers includes experts and key opinion leaders. Among them are Professor Christine Moffatt (England), Dr Stanley Rockson (United States), and Professor Keith Harding (Wales).
A special focus of the conference is on the ILF’s research and projects. The recently published results of the international LIMPRINT study will be presented, and the Chronic Oedema Outcome Measure project will be highlighted in a poster exhibition launching the first results from 12 national frameworks. Both projects are examples of ILF’s work in identifying key priority areas that are inhibiting the recognition of chronic oedema as a major, emerging public health care problem.
On Friday, 13 June, special interactive sessions will be targeted at primary care physicians and nurses interested in learning more about how to recognise lymphoedema and the standards of care. On Friday afternoon and Saturday, a special patient summit will offer patients the opportunity to learn from lymphoedema experts around the world.
With the 9th International Lymphoedema Framework Conference, the ILF and the ALFP hope to bring us one step closer to improving care (and access to care) for the more than 120 million people around the world affected by this chronic disease.
Christine Moffatt Jane Armer
ILF Chair ALFP Director
Download International version:
Download USA version: